Literature DB >> 20727589

Antiangiogenic therapy accelerates tumor metastasis.

Domenico Ribatti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20727589     DOI： 10.1016/j.leukres.2010.07.038

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  8 in total

1.  Metastasis is impaired by endothelial-specific Dll4 loss-of-function through inhibition of epithelial-to-mesenchymal transition and reduction of cancer stem cells and circulating tumor cells.

Authors:  Liliana Mendonça; Alexandre Trindade; Catarina Carvalho; Jorge Correia; Marina Badenes; Joana Gigante; António Duarte
Journal:  Clin Exp Metastasis       Date:  2019-05-22       Impact factor: 5.150

2.  Inhibition of lymphangiogenesis and angiogenesis in breast tumor xenografts and lymph nodes by a peptide derived from transmembrane protein 45A.

Authors:  Esak Lee; Jacob E Koskimaki; Niranjan B Pandey; Aleksander S Popel
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

3.  The inefficacy of antiangiogenic therapies.

Authors:  Domenico Ribatti
Journal:  J Angiogenes Res       Date:  2010-12-10

4.  Sales for anti-angiogenic drugs.

Authors:  Domenico Ribatti
Journal:  Oncotarget       Date:  2017-06-13

5.  Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.

Authors:  Melissa García-Caballero; Jenny Paupert; Silvia Blacher; Maureen Van de Velde; Ana Rodríguez Quesada; Miguel Angel Medina; Agnès Noël
Journal:  J Hematol Oncol       Date:  2017-06-19       Impact factor: 17.388

6.  Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.

Authors:  Tingting Qin; Zhujun Liu; Jing Wang; Junling Xia; Shaochuan Liu; Yanan Jia; Hailin Liu; Kai Li
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

7.  EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma.

Authors:  Yi Huang; Tao Yu; Xiaoyue Fu; Jiao Chen; Ying Liu; Chunjie Li; Yichao Xia; Zhuoyuan Zhang; Longjiang Li
Journal:  BMC Cell Biol       Date:  2013-03-09       Impact factor: 4.241

8.  Lymph microvascularization as a prognostic indicator in neuroblastoma.

Authors:  Irene Tadeo; Esther Gamero-Sandemetrio; Ana P Berbegall; Marta Gironella; Félix Ritort; Adela Cañete; Gloria Bueno; Samuel Navarro; Rosa Noguera
Journal:  Oncotarget       Date:  2018-05-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.